These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 34051480)
21. Pharmacokinetic studies of a novel tubulin inhibitor SK1326 in rat plasma by UPLC-MS/MS. Ji YS; Kim TK Biomed Chromatogr; 2020 Apr; 34(4):e4749. PubMed ID: 31743475 [TBL] [Abstract][Full Text] [Related]
22. Determination of sparstolonin B by ultra-high performance liquid chromatography coupled with triple quadrupole mass spectrometry: application to pharmacokinetic study of sparstolonin B in rat plasma. Zou NS; Liang QL; Li P; Liu J; Liu X; Kang A; Deng HS Biomed Chromatogr; 2015 Oct; 29(10):1486-91. PubMed ID: 25731641 [TBL] [Abstract][Full Text] [Related]
23. Development and validation of a UPLC-MS/MS method for determination of motesanib in plasma: Application to metabolic stability and pharmacokinetic studies in rats. Ezzeldin E; Iqbal M; Al-Salahi R; El-Nahhas T J Pharm Biomed Anal; 2019 Mar; 166():244-251. PubMed ID: 30665192 [TBL] [Abstract][Full Text] [Related]
24. Simultaneous determination of asperosaponin VI and its active metabolite hederagenin in rat plasma by liquid chromatography-tandem mass spectrometry with positive/negative ion-switching electrospray ionization and its application in pharmacokinetic study. Zhu H; Ding L; Shakya S; Qi X; Hu L; Yang X; Yang Z J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3407-14. PubMed ID: 21963276 [TBL] [Abstract][Full Text] [Related]
25. Development and validation of a high throughput bioanalytical UPLC-MS/MS method for simultaneous determination of tamoxifen and sulphoraphane in rat plasma: Application to an oral pharmacokinetic study. Mangla B; Alam O; Rub RA; Iqbal M; Singh A; Patel KS; Kohli K J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122260. PubMed ID: 32679526 [TBL] [Abstract][Full Text] [Related]
26. Simultaneous UFLC-ESI-MS/MS determination of piperine and piperlonguminine in rat plasma after oral administration of alkaloids from Piper longum L.: application to pharmacokinetic studies in rats. Liu J; Bi Y; Luo R; Wu X J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(27):2885-90. PubMed ID: 21903488 [TBL] [Abstract][Full Text] [Related]
27. A validated LC-MS/MS method for the determination of RAF inhibitor LXH254: Application to pharmacokinetic study in rat. Li R; Ren M; Lu W; Yuan Y; Li J; Zhong W Biomed Chromatogr; 2021 Feb; 35(2):e4968. PubMed ID: 32881002 [TBL] [Abstract][Full Text] [Related]
28. Determination of deltonin in rat plasma by using HPLC-MS/MS and the application of this method in pharmacokinetic studies. Du D; Gao B; Xin G; Sun A; Huang B; Zhang R; Xing Z; Chen Q; He Y; Huang W J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():1-5. PubMed ID: 23747424 [TBL] [Abstract][Full Text] [Related]
29. Quantitative determination of gracillin by HPLC-MS/MS after oral administration and its application to a pharmacokinetic study. Zhang X; Xue X; Zhao J; Guo Z; Ito Y; Sun W Steroids; 2016 Sep; 113():78-86. PubMed ID: 27394958 [TBL] [Abstract][Full Text] [Related]
30. Determination of cefadroxil in rat plasma and urine using LC-MS/MS and its application to pharmacokinetic and urinary excretion studies. Jin HE; Kim IB; Kim YC; Cho KH; Maeng HJ J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 947-948():103-10. PubMed ID: 24412692 [TBL] [Abstract][Full Text] [Related]
31. Determination of astragaloside III in rat plasma by liquid chromatography-tandem mass spectrometry and its application to a rat pharmacokinetic study. Zhai Y; Li P; Wang M; Gong M; Qiu F Biomed Chromatogr; 2016 Feb; 30(2):105-10. PubMed ID: 26031660 [TBL] [Abstract][Full Text] [Related]
32. Simultaneous Determination of Bosentan, Glimepiride, HYBOS and M1 in Rat Plasma by UPLC-MS-MS and its Application to Pharmacokinetic Study. Chen M; Song W; Wang S; Chen Q; Pan P; Xu T; Hu G; Zheng Z J Chromatogr Sci; 2016 Aug; 54(7):1159-65. PubMed ID: 27240565 [TBL] [Abstract][Full Text] [Related]
33. Simultaneous determination of acetylpuerarin and puerarin in rat plasma by liquid chromatography-tandem mass spectrometry: Application to a pharmacokinetic study following intravenous and oral administration. Sun D; Xue A; Wu J; Zhang B; Yu J; Li Q; Sun C J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jul; 995-996():24-30. PubMed ID: 26021848 [TBL] [Abstract][Full Text] [Related]
34. Determination of cefdinir levels in rat plasma and urine by high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral and intravenous administration of cefdinir. Jin HE; Kim IB; Kim CK; Maeng HJ Biomed Chromatogr; 2013 Nov; 27(11):1423-30. PubMed ID: 23712418 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and bioavailability study of ginsenoside Rk1 in rat by liquid chromatography/electrospray ionization tandem mass spectrometry. Li J; Zhang Y; Fan A; Li G; Liu Q Biomed Chromatogr; 2019 Sep; 33(9):e4580. PubMed ID: 31077415 [TBL] [Abstract][Full Text] [Related]
36. Determination of GL-V9, a derivative of wogonin, in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study after oral and pulmonary administration. Xing H; Ren C; Kong Y; Ni Q; Wang Z; Zhao D; Li N; Chen X; Lu Y Biomed Chromatogr; 2019 Aug; 33(8):e4556. PubMed ID: 30990904 [TBL] [Abstract][Full Text] [Related]
37. Quantification of 2'-deoxy-2'-β-fluoro-4'-azidocytidine in rat and dog plasma using liquid chromatography-quadrupole time-of-flight and liquid chromatography-triple quadrupole mass spectrometry: Application to bioavailability and pharmacokinetic studies. Peng Y; Cheng T; Dong L; Zhang Y; Chen X; Jiang J; Zhang J; Guo X; Guo M; Chang J; Wang Q J Pharm Biomed Anal; 2014 Sep; 98():379-86. PubMed ID: 24999865 [TBL] [Abstract][Full Text] [Related]
38. Determination and validation of hupehenine in rat plasma by UPLC-MS/MS and its application to pharmacokinetic study. Wen C; Wang S; Huang X; Liu Z; Lin Y; Yang S; Ma J; Zhou Y; Wang X Biomed Chromatogr; 2015 Dec; 29(12):1805-10. PubMed ID: 26033449 [TBL] [Abstract][Full Text] [Related]
39. UHPLC-MS/MS method for the quantification of aloin-A in rat plasma and its application to a pharmacokinetic study. Niu C; Ye W; Cui X; Sun J; Xiao S; Chen G; Bao S; Chen R J Pharm Biomed Anal; 2020 Jan; 178():112928. PubMed ID: 31708267 [TBL] [Abstract][Full Text] [Related]
40. A validated UPLC-MS/MS method for pharmacokinetic study of inflachromene, a novel microglia inhibitor. Lee HH; Im SH; Ahn S; Bae MA; Park SB; Kim SK; Song JS J Pharm Biomed Anal; 2019 Mar; 166():183-188. PubMed ID: 30654206 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]